RBM15B Regulates progression of MLL-rearranged leukemia
ChIP-seq / ATAC-seq (genome binding and open chromatin) · human · 36 samples
- What it is
- ChIP-seq / ATAC-seq (genome binding and open chromatin)Where proteins bind the genome, or which regions are open and active.
- Organism
- Homo sapiens (human)
- Samples
- 36 samples: 9 × DMSO-treated vs 9 × EPZ5676-treated vs 6 × RBM15B-knockdown vs 6 × RBM15B-NCGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
- Paper
- RBM15B recognizes H3K79me2 to guide selective m(6)A-modification of mRNA and enhance oncoprotein translation in MLL-r leukemiaThe EMBO journal · 2026
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE237261_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: Look for peak files (.bed, .narrowPeak) and signal tracks (.bigWig) among the supplementary files; the raw reads are on ENA.
Also filed as BioProject PRJNA994487 and SRA study SRP449319. Searching any of these in the dataset finder brings you back here.
Supports a between-group comparison across 30 samples.
How we read this: 4 replicated groups read from 36 sample titles; they account for 30 of them. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM7598034 meRIP seq of MOLM13:DMSO-treated rep1 DMSO-treated
- GSM7598035 meRIP seq of MOLM13:EPZ5676-treated rep1 EPZ5676-treated
- GSM7598036 meRIP seq Input of MOLM13:DMSO-treated rep1 DMSO-treated
- GSM7598037 meRIP seq Input of MOLM13:EPZ5676-treated rep1 EPZ5676-treated
- GSM7598038 meRIP seq of MOLM13:DMSO-treated rep2 DMSO-treated
- GSM7598039 meRIP seq of MOLM13:EPZ5676-treated rep2 EPZ5676-treated
- GSM7598040 meRIP seq Input of MOLM13:DMSO-treated rep2 DMSO-treated
- GSM7598041 meRIP seq Input of MOLM13:EPZ5676-treated rep2 EPZ5676-treated
- GSM7598042 meRIP seq of MOLM13:DMSO-treated rep3 DMSO-treated
- GSM7598043 meRIP seq of MOLM13:EPZ5676-treated rep3 EPZ5676-treated
- GSM7598044 meRIP seq Input of MOLM13:DMSO-treated rep3 DMSO-treated
- GSM7598045 meRIP seq Input of MOLM13:EPZ5676-treated rep3 EPZ5676-treated
- GSM7598046 meRIP seq Input of MOLM13:RBM15B-knockdown rep1 RBM15B-knockdown
- GSM7598047 meRIP seq of MOLM13:RBM15B-knockdown rep1 RBM15B-knockdown
- GSM7598048 meRIP seq Input of MOLM13:RBM15B-knockdown rep2 RBM15B-knockdown
- GSM7598049 meRIP seq of MOLM13:RBM15B-knockdown rep2 RBM15B-knockdown
- GSM7598050 meRIP seq Input of MOLM13:RBM15B-knockdown rep3 RBM15B-knockdown
- GSM7598051 meRIP seq of MOLM13:RBM15B-knockdown rep3 RBM15B-knockdown
- GSM7598052 meRIP seq Input of MOLM13:RBM15B-NC rep1 RBM15B-NC
- GSM7598053 meRIP seq of MOLM13:RBM15B-NC rep1 RBM15B-NC
- GSM7598054 meRIP seq Input of MOLM13:RBM15B-NC rep2 RBM15B-NC
- GSM7598055 meRIP seq of MOLM13:RBM15B-NC rep2 RBM15B-NC
- GSM7598056 meRIP seq Input of MOLM13:RBM15B-NC rep3 RBM15B-NC
- GSM7598057 meRIP seq of MOLM13:RBM15B-NC rep3 RBM15B-NC
- GSM9219794 CUT&Tag seq of MOLM13:EPZ5676-treated rep1 EPZ5676-treated
- GSM9219795 CUT&Tag seq of MOLM13:EPZ5676-treated rep2 EPZ5676-treated
- GSM9219796 CUT&Tag seq of MOLM13:EPZ5676-treated rep3 EPZ5676-treated
- GSM9219797 CUT&Tag seq of MOLM13:DMSO-treated rep1 DMSO-treated
- GSM9219798 CUT&Tag seq of MOLM13:DMSO-treated rep2 DMSO-treated
- GSM9219799 CUT&Tag seq of MOLM13:DMSO-treated rep3 DMSO-treated
- GSM9219800 CUT&Tag seq of MOLM13:EPZ5676-treated rep1_IgG
- GSM9219801 CUT&Tag seq of MOLM13:EPZ5676-treated rep2_IgG
- GSM9219802 CUT&Tag seq of MOLM13:EPZ5676-treated rep3_IgG
- GSM9219803 CUT&Tag seq of MOLM13:DMSO-treated rep1_IgG
- GSM9219804 CUT&Tag seq of MOLM13:DMSO-treated rep2_IgG
- GSM9219805 CUT&Tag seq of MOLM13:DMSO-treated rep3_IgG
- GSE273999 A 3D genome atlas of breast cancer progression 31 samples shares progression
- GSE256354 Hypomethylating agents induce epigenetic and transcriptional heterogeneity with implications for acute myeloid leukemia cell self-renewal 2765 samples shares leukemia
- GSE268035 STAG2 Mutations Reshape the Cohesin-Structured Spatial Chromatin Architecture to Drive Gene Regulation in Acute myeloid Leukemia 541 samples shares leukemia
- GSE304097 DNA methylation profiling identifies long-range epigenetic silencing of clustered protocadherins as a key determinant of meningioma progression 293 samples shares progression
- GSE309697 Generation of a Comprehensive Epigenomic Atlas in Clear Cell Renal Cell Carcinoma Informs Kidney Cancer Progression and Heritability 265 samples shares progression
- GSE289044 Spatial proteo-transcriptomic profiling reveals the molecular landscape of borderline ovarian tumors and their invasive progression 252 samples shares progression
- GSE274680 Inflammation and lymphocyte activation during longitudinal progression to rheumatoid arthritis in at-risk individuals 243 samples shares progression
- GSE270787 ZIC2 and ZIC3 promote SWI/SNF recruitment to safeguard progression towards human primed pluripotency 205 samples shares progression
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.